New York, NY (December 21, 2009) – Clinilabs, an early-phase and specialty contract research organization (CRO), announced today that Ms. Lynn Aneiro has joined the company as the Director of Global Clinical Trial Operations, leading a new business unit that expands Clinilabs’ multicenter clinical trial capabilities.
Prior to joining Clinilabs, Ms. Aneiro was the Senior Director of Clinical Operations for the Neurogen Corporation, a biotechnology company with compounds in early clinical development. Before her work at Neurogen, Ms. Aneiro was an employee of the Bayer Corporation for several years, where she held progressively responsible positions managing phase II – IV clinical trials. Ms. Aneiro earned a BS in Biochemistry from Trinity College, an MHS in Medical Laboratory Sciences from Quinnipiac College, and Professional Certification in Human Resource Management from the University of New Haven.
Dr. Gary Zammit, President and CEO of Clinilabs, stated, “Clinilabs is pleased to welcome Lynn to a high level position in our organization. We had the distinct pleasure of providing services to her team at Neurogen for several years, so we enjoy familiarity with her approach to clinical research, and we know how valuable Lynn will be to our clients who require multicenter project management.”
Ms. Aneiro stated, “You can be sure that my team understands the needs of clients involved in early phase and specialty studies. Having been with sponsoring companies for a number of years, I have experienced first-hand the challenges that clients encounter when outsourcing work to CROs. We have something different at Clinilabs, where performance factors such as open communication, high quality work, timely deliverables, and controlling costs meet or exceed the expectations of our clients. It is a pleasure to assume a leadership position in a company that is making this kind of difference in the industry.”
About Clinilabs Inc.
Clinilabs is a contract research organization (CRO) that provides early phase and specialty clinical drug development services to industry. Our organization offers clients a turn-key solution for single center and multicenter Phase I and II clinical trials. We also offer specialty drug development services in a variety of therapeutic areas. For more information, please visit www.clinilabs.com.
